Overview

Study of the Antiviral and Immunological Effects of Intensification of Suppressive Antiretroviral Therapy With Maraviroc

Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
Hypothesis: Intensification of current ARV regimens with maraviroc will result in more complete suppression of viral replication, particularly in the gastrointestinal mucosa with resultant reduction in markers of immune activation and improved GI immune reconstitution.
Phase:
Phase 1
Details
Lead Sponsor:
Rockefeller University
Collaborators:
Aaron Diamond AIDS Research Center
Pfizer
Treatments:
Abacavir
Antiviral Agents
Maraviroc
Protease Inhibitors
Tenofovir